There are multiple factors which can increase patients’ risk of oral cancer, including alcohol intake, tobacco use, and HPV status. As such, when you spot an unusual lesion, it can be very helpful to conduct a pre-diagnostic test to help establish whether it is likely to be oral cancer.
The BeVigilant™ OraFusion™ System from Vigilant Biosciences is designed to improve outcomes by enabling clinicians to intervene earlier. The system is:
- Accurate, using simple biomarkers along with clinical risk factors to provide an informed risk assessment
- Non-invasive, using a simple saliva test
- Fast, offering results in 15 minutes or less – ideal for chairside use
If you’d like to find out more about BeVigilant™ OraFusion™ system, please visit the website and contact the team.
For more information, please visit www.vigilantbiosciences.com or email info@vigilantbiosciences.com
